Johnson & Johnson
The Director, New Products Value and Evidence leads U.S. market access scientific strategy, evidence generation, and dissemination planning for pipeline products at Johnson & Johnson. This role involves anticipating evolving payer and policy requirements to support evidence-based development decisions, launch readiness, and sustained patient access. The position requires integrating real-world evidence into development plans and managing cross-functional partnerships to ensure compliant scientific exchange and value communication.
Headquarters
New Brunswick, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Johnson & Johnson is a global healthcare company that develops, manufactures and sells pharmaceuticals (through Janssen), medical devices and consumer health products. The company emphasizes research and innovation to prevent and cure complex diseases and to make treatments smarter, less invasive and more personalized. Operating worldwide, J&J partners with health systems, researchers and communities and invests heavily in R&D to "change health for humanity."
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Johnson & Johnson.
Right around the average for this role
Associate Director, Real World Value and Evidence – Oncology Solid Tumor
Johnson & Johnson Medical Korea Limited
Principal, Evidence Generation
Trinity Life Sciences
Director, Value & Evidence Strategy
alnylam
Principal Scientist/Director, Value & Implementation (V&I) Outcomes Research
MSD
Director, HEOR & Value Evidence
Telix Pharmaceuticals
Lead Value Evidence, MA-US
Astellas